7 Matching Annotations
  1. Sep 2024
  2. link.springer.com link.springer.com
    Interruption of MDM2 signaling augments MDM2-targeted T cell-based antitumor immunotherapy through antigen-presenting machinery
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    link.springer.com/article/10.1007/s00262-021-02940-5
  3. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    Hypoxia-Targeted Immunotherapy with PD-1 Blockade in Head and Neck Cancer
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC11394489/
  4. Apr 2024
  5. onlinelibrary.wiley.com onlinelibrary.wiley.com
    Immunotherapy targeting tumor-associated antigen in a mouse model of head and neck cancer
    2
    Visit annotations in context

    Tags

    Annotators

    URL

    onlinelibrary.wiley.com/doi/10.1002/hed.27703
  6. May 2023
  7. link.springer.com link.springer.com
    Brachyury-targeted immunotherapy combined with gemcitabine against head and neck cancer
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    link.springer.com/article/10.1007/s00262-023-03460-0
  8. Feb 2023
  9. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    Mitogen‐activated protein kinase inhibition augments the T cell response against HOXB7‐expressing tumor through human leukocyte antigen upregulation
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC9899601/
  10. Jan 2022
  11. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    Immunomodulation via FGFR inhibition augments FGFR1 targeting T-cell based antitumor immunotherapy for head and neck squamous cell carcinoma
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC8741288/